Frontline treatment with chemoimmunotherapy for limited-stage ocular adnexal MALT lymphoma with adverse factors: a phase II study
about
Frontline treatment with chemoimmunotherapy for limited-stage ocular adnexal MALT lymphoma with adverse factors: a phase II study
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Frontline treatment with chemo ...... erse factors: a phase II study
@en
Frontline treatment with chemo ...... erse factors: a phase II study
@nl
type
label
Frontline treatment with chemo ...... erse factors: a phase II study
@en
Frontline treatment with chemo ...... erse factors: a phase II study
@nl
prefLabel
Frontline treatment with chemo ...... erse factors: a phase II study
@en
Frontline treatment with chemo ...... erse factors: a phase II study
@nl
P2093
P2860
P356
P1433
P1476
Frontline treatment with chemo ...... erse factors: a phase II study
@en
P2093
Deok-Hwan Yang
Hee Bae Ahn
Hyo Jung Kim
Jae Wook Yang
Jee Ho Chang
Min Joung Lee
Seok-Goo Cho
Seong Kyu Park
Suk-Woo Yang
Sung Yong Oh
P2860
P304
68583-68590
P356
10.18632/ONCOTARGET.19788
P407
P577
2017-08-02T00:00:00Z